Pharma Stocks
-
How Investors Are Reacting To BridgeBio Pharma (BBIO) Phase 2 Data and Upcoming Pipeline Milestones
BridgeBio Pharma recently announced new Phase 2 clinical findings for encaleret in post-surgical hypoparathyroidism and detailed several upcoming presentations on…
Read More » -
Anil Rego cautious on US-exposed pharma stocks; warns against underestimating tariff-led global slowdown
From an investment perspective, Anil Rego, Founder and Fund Manager at Right Horizons PMS, said he would be cautious on…
Read More » -
Pharma stocks drop despite limited impact from new U.S. drug tariffs
Major drug company shares declined Friday after President Donald Trump announced 100% tariffs on imported branded medications, though analysts believe…
Read More » -
Why pharma stocks aren’t getting hit by new tariff threats
President Trump’s tariff threats don’t sting as much as they used to. On Thursday evening, Trump announced on Truth Social…
Read More » -
Big pharma stocks rise as Street reacts to latest presidential tariff plan
Shares of some big drugmakers rose Friday as Wall Street started sorting out the impact of President Donald Trump’s latest…
Read More » -
Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in
For Indian pharmaceutical exports, the US represents the primary market, comprising approximately 35% of total exports, with a value reaching…
Read More » -
Pharma stocks in focus as Trump announces 100% tariff on pharma products; check details
Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL…
Read More » -
Jim Cramer Highlights Jacobs Solutions Role in Data Centers and Pharma Projects
Jacobs Solutions Inc. (NYSE:J) is one of the relatively cheap S&P 500 stocks Jim Cramer talked about. During the episode,…
Read More » -
Alembic Pharma Gets USFDA Nod for Paroxetine ER
Vadodara, September 25, 2025: Alembic Pharmaceuticals Ltd (NSE: APLLTD, BSE: 533573) has received final USFDA approval of its ANDA filing…
Read More » -
Solara Active Pharma Soars 10.38% to Hit Intraday High of Rs 711.2
Solara Active Pharma Sciences experienced a notable turnaround today, recovering from previous declines and outperforming its sector. The stock showed…
Read More »